Wed, September 20, 2023
Tue, September 19, 2023
Mon, September 18, 2023
Fri, September 15, 2023
Thu, September 14, 2023
Wed, September 13, 2023

Joseph Pantginis Maintained (BLRX) at Strong Buy with Increased Target to $21 on, Sep 15th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-21-on-sep-15th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Pantginis of HC Wainwright & Co., Maintained "BioLineRx Ltd." (BLRX) at Strong Buy with Increased Target from $19 to $21 on, Sep 15th, 2023.

Joseph has made no other calls on BLRX in the last 4 months.



There is 1 other peer that has a rating on BLRX. Out of the 1 peers that are also analyzing BLRX, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Mark Breidenbach of "Oppenheimer" Reiterated at Buy and Held Target at $4 on, Thursday, May 25th, 2023

Publication Contributing Sources